National Health Investors, Inc. (NHI)
National Health Investors (NHI) Misses Q4 FFO Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.22 per share, missing the Zacks Consensus Estimate of $1.24 per share. This compares to FFO of $1.13 per share a year ago.
National Health Investors (NHI) Is Up 2.37% in One Week: What You Should Know
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
National Health Investors: A Healthcare REIT Ready For The Senior Housing Supercycle
National Health Investors is rated a Buy thanks to strong financials, manageable debt, and a compelling 4.7% dividend yield. NHI's transition to a SHOP-oriented model is driving normalized FAD growth, with Q3'25 FAD up 26% year-over-year and guidance raised for 2025. A low leverage profile, very attractive debt maturity schedule, and significant liquidity position NHI favorably in the senior housing REIT space.
National Health Investors (NHI) Moves to Buy: Rationale Behind the Upgrade
National Health Investors (NHI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
National Health Investors Q3: Beat And Raise From Senior Housing Boom
National Health Investors, Inc. is rated a Buy for income-focused investors seeking exposure to senior housing REITs. NHI boasts a 4.7% dividend yield, strong Q3 results, conservative debt management, and over $1 billion in liquidity supporting dividend safety and growth. NHI's total return has outperformed the real estate sector over the past decade, with demographic trends and raised guidance pointing to continued growth.
National Health Investors, Inc. (NHI) Q3 2025 Earnings Call Transcript
National Health Investors, Inc. ( NHI ) Q3 2025 Earnings Call November 7, 2025 10:00 AM EST Company Participants Dana Hambly - Vice President of Finance & Investor Relations D. Mendelsohn - President, CEO & Director Kevin Pascoe - Executive VP of Investments & Chief Investment Officer John Spaid - Executive VP of Finance, CFO & Treasurer Conference Call Participants Juan Sanabria - BMO Capital Markets Equity Research Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division Farrell Granath - BofA Securities, Research Division Richard Anderson - Cantor Fitzgerald & Co., Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Greetings, and welcome to the NHI's Third Quarter 2025 Earnings Webcast and Conference Call.
National HealthCare Is Thriving And Will Shrug Off NHI Lease Expiration
NHC's fundamentals are robust, with strong earnings, revenue, and margin growth. Despite recent underperformance in total return, operating margins have expanded significantly and are likely to continue improving, supported by favorable industry trends. Concerns about the 2027 NHI lease expiration are overblown; NHC can absorb rent increases or purchase properties outright thanks to low debt and rising cash.
National Health Investors: 5% Yield And Robust Growth In Plain Sight
National Health Investors offers attractive growth and income, with robust SHOP margins, improving rent coverage, and accelerating portfolio transitions fueling FFO and NOI expansion. NHI's strong balance sheet, conservative leverage, and well-covered 4.8% dividend support NHI's investment case, with management guiding for 8% FFO growth this year. NHI offers income and growth at a reasonable price for investors seeking value outside of the tech sector.
National Health Investors, Inc. (NHI) Q2 2025 Earnings Call Transcript
National Health Investors, Inc. (NYSE:NHI ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants D. Eric Mendelsohn - President, CEO & Director Dana Rolfson Hambly - Vice President of Finance & Investor Relations John L.
National Health Investors (NHI) Tops Q2 FFO Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to FFO of $1.18 per share a year ago.
National Health Investors, Inc. (NHI) Q1 2025 Earnings Call Transcript
National Health Investors, Inc. (NYSE:NHI ) Q1 2025 Earnings Conference Call May 6, 2025 10:00 AM ET Company Participants Dana Hambly – Vice President, Finance and Investor Relations Eric Mendelsohn – President and CEO Kevin Pascoe – Chief Investment Officer John Spaid – Chief Financial Officer David Travis – Chief Accounting Officer Conference Call Participants Rich Anderson – Wedbush Juan Sanabria – BMO Capital Markets Farrell Granath – Bank of America Omotayo Okusanya – Deutsche Bank Austin Wurschmidt – KeyBanc Capital Markets Operator Greetings. Welcome to National Health Investors First Quarter 2025 Earnings Webcast and Conference Call.
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.15 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to FFO of $1.10 per share a year ago.
